Nicolas S. Galvez

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.

Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.

Journal: Current research in microbial sciences
Published: July 31, 2025

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Journal: iScience
Published: February 14, 2025

Tree-Cavity Denning of Güiña (Leopardus guigna) and Breeding Productivity From Camera Trap Records.

Tree-Cavity Denning of Güiña (Leopardus guigna) and Breeding Productivity From Camera Trap Records.

Journal: Ecology and evolution
Published: December 27, 2024

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.

Journal: Frontiers in immunology
Published: May 02, 2023

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults.

Journal: EBioMedicine
Published: December 19, 2022

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern.

Journal: mBio
Published: August 10, 2022

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

Journal: eLife
Published: June 29, 2022

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial.

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial.

Journal: Vaccines
Published: May 27, 2022

BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus.

BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus.

Journal: Vaccines
Published: April 09, 2022

BCG vaccination induces cross-protective immunity against pathogenic microorganisms.

BCG vaccination induces cross-protective immunity against pathogenic microorganisms.

Journal: Trends in immunology
Published: November 01, 2021

The Causes and Long-Term Consequences of Viral Encephalitis.

The Causes and Long-Term Consequences of Viral Encephalitis.

Journal: Frontiers in cellular neuroscience
Published: August 09, 2021

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.

Journal: Frontiers in immunology
Published: July 26, 2021
Showing 1-12 of 33

Last Updated: 09/26/2026